Cost Analysis of Candida Infection among Surgical Intensive Care Unit Patients
- 6 Downloads
The purpose of this study was to identify all hospital costs associated with surgical intensive care unit (SICU) patients who were at risk from or had documented systemic Candida infection. All patients admitted or transferred to the SICU in February 1993 were eligible. Of the 117 patients evaluated, many had recognised risk factors for systemic Candida infection, but based on eventual outcome, only 20 (17% of those admitted) were evaluated as high risk, i.e. those in the SICU ≥ 4 days on broad spectrum antibacterials with continued fever, hypothermia, or use of corticosteroids. When comparing the high risk group with a lower risk group, the increase in cost of hospital care was approximately $US41 000 per patient. Future clinical studies should evaluate if empirical antifungal agents can impact on the morbidity, mortality and economic burden incurred by Candida infection in high risk SICU patients.
Unable to display preview. Download preview PDF.
- 9.Edwards Jr JE. Candida species. In: Mandell GL, Douglas Jr RG, Bennett JE, editors. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990: 1943–58Google Scholar
- 15.Sugar AM. Problems in the diagnosis of invasive candidiasis in the immunocompromised patient. In: Richardson RG, editor. Opportunistic fungal infections: focus on fluconazole. International Congress and Symposium Series No. 153. London: Royal Society of Medicine Services Ltd, 1989: 17–24Google Scholar
- 16.Edwards Jr JE. Candidemia and Candida catheter-associated sepsis. In: Holmberg K, Meyer RD, editors. Diagnosis and therapy of systemic fungal infections. New York: Raven Press, 1989: 39–46Google Scholar
- 17.Fass RJ, Goff DA, Sierawski SJ. Candida infections in the surgical intensive care unit (SICU). J Antimicrobial Chemother. In pressGoogle Scholar